13F filer · CIK 1422849 ↗

Capital World Investors

You are looking at Q4 2018. See the latest, Q2 2026 →

Reported value

$369.11B

−10% on the quarter before

Positions

529

39 new · 66 sold out

Top 10

24.8%

of the value

Est. gain

−$48.82B

on stocks held all quarter

Est. return

−12.9%

on those stocks since Q3 2018

Filed

Feb 14, 2019

On SEC EDGAR ↗

Positions as of Dec 31, 2018, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 42% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.

Microsoft5.1%Broadcom3.2%
Unitedhealth Group Inc2.7%
Home Depot Inc2.7%
Dowdupont Inc2.0%
Jpmorgan Chase And Co1.9%
Merck And Co Inc1.9%
Berkshire Hathaway Inc Cl A1.9%
Amazon1.8%
Cme Group Inc Cl A1.7%
Intel1.6%Meta1.5%
Pfizer Inc1.5%
Boeing Co1.3%
Nike Inc Cl B1.3%
Lockheed Martin Corp1.3%
Conocophillips1.2%
Alphabet1.2%
Coca-Cola Co1.1%
Mastercard1.1%
Verizon Communications Inc1.1%
Alphabet1.0%
Boston Scientific Corp1.0%
Philip Morris International1.0%

Largest buys

Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Cigna Corp~$3.20BNew · 0.0% → 0.9%+16,848,497 shares
  2. Linde Plc~$2.81BNew · 0.0% → 0.8%+17,950,099 shares
  3. Pfizer Inc~$1.76BAdded · 0.9% → 1.5%+40,389,680 shares
  4. Meta~$1.24BAdded · 1.3% → 1.5%+9,468,827 shares
  5. Pnc Financial Services Group Inc~$1.14BAdded · 0.5% → 0.8%+9,752,000 shares
  6. Broadcom~$1.08BAdded · 2.6% → 3.2%+4,234,197 shares
  7. Keurig Dr Pepper Inc~$856.9MAdded · 0.0% → 0.3%+33,420,740 shares
  8. Jpmorgan Chase And Co~$796.4MAdded · 1.8% → 1.9%+8,158,089 shares
  9. Cme Group Inc Cl A~$709.4MAdded · 1.2% → 1.7%+3,771,076 shares
  10. Activision Blizzard Inc~$693.8MAdded · 0.6% → 0.6%+14,899,037 shares

Largest sells

Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Aetna Inc~$1.53BSold out · 0.4% → 0.0%−7,540,143 shares
  2. Express Scripts Holding Co~$1.50BSold out · 0.4% → 0.0%−15,774,222 shares
  3. Wells Fargo And Co~$1.42BCut · 0.7% → 0.3%−30,843,791 shares
  4. Amazon~$1.15BCut · 2.5% → 1.8%−763,262 shares
  5. Cigna Corp~$1.14BSold out · 0.3% → 0.0%−5,464,526 shares
  6. Philip Morris International~$745.2MCut · 1.3% → 1.0%−11,161,629 shares
  7. Caterpillar Inc~$676.0MCut · 0.6% → 0.4%−5,319,523 shares
  8. Amgen Inc~$645.9MCut · 0.2% → 0.1%−3,318,062 shares
  9. Booking Holdings Inc~$641.0MCut · 0.3% → 0.2%−372,156 shares
  10. IBM~$597.3MSold out · 0.1% → 0.0%−3,950,000 shares

Holdings

As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOMMON STOCK · shares −0.06% · price −11.2%5.1%$18.83B−$2.37B
BroadcomCOMMON STOCK · shares +9.9% · price +3.1%3.2%$11.90B+$321.4M
Unitedhealth Group IncCOMMON STOCK · shares +3.0% · price −6.4%2.7%$9.83B−$647.7M
Home Depot IncCOMMON STOCK · shares +0.6% · price −17.1%2.7%$9.82B−$2.01B
Dowdupont IncCOMMON STOCK · shares +6.4% · price −16.8%2.0%$7.49B−$1.43B
Jpmorgan Chase And CoCOMMON STOCK · shares +13% · price −13.5%1.9%$7.05B−$974.5M
Merck And Co IncCOMMON STOCK · shares +5.1% · price +7.7%1.9%$7.01B+$477.6M
Berkshire Hathaway Inc Cl ACOMMON STOCK · shares −1.2% · price −4.4%1.9%$6.84B−$313.1M
AmazonCOMMON STOCK · shares −15% · price −25.0%1.8%$6.52B−$2.17B
Cme Group Inc Cl ACOMMON STOCK · shares +13% · price +10.5%1.7%$6.15B+$517.7M
IntelCOMMON STOCK · shares −3.0% · price −0.8%1.6%$6.02B−$46.2M
MetaCOMMON STOCK · shares +29% · price −20.3%1.5%$5.59B−$1.11B
Pfizer IncCOMMON STOCK · shares +47% · price −1.0%1.5%$5.47B−$35.7M
Boeing CoCOMMON STOCK · shares −2.2% · price −13.3%1.3%$4.95B−$758.1M
Nike Inc Cl BCOMMON STOCK · shares −1.6% · price −12.5%1.3%$4.73B−$675.1M
Lockheed Martin CorpCOMMON STOCK · shares +7.2% · price −24.3%1.3%$4.64B−$1.39B
ConocophillipsCOMMON STOCK · shares +8.6% · price −19.4%1.2%$4.47B−$993.0M
AlphabetCOMMON STOCK · shares +8.6% · price −13.2%1.2%$4.37B−$613.3M
Coca-Cola CoCOMMON STOCK · shares +8.7% · price +2.5%1.1%$4.22B+$95.1M
MastercardCOMMON STOCK · shares +8.1% · price −15.3%1.1%$3.90B−$649.9M
Verizon Communications IncCOMMON STOCK · shares −3.4% · price +5.3%1.1%$3.89B+$196.1M
AlphabetCOMMON STOCK · shares +2.8% · price −13.4%1.00%$3.69B−$556.6M
Boston Scientific CorpCOMMON STOCK · shares +11% · price −8.2%0.96%$3.53B−$283.9M
Philip Morris InternationalCOMMON STOCK · shares −17% · price −18.1%0.96%$3.53B−$780.6M
General Motors CompanyCOMMON STOCK · shares +24% · price −0.7%0.94%$3.47B−$18.5M
Total · 529 positions100%$369.11B−$48.82B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2018 to Q4 2018: 482 stocks held throughout, down $48.82B (−12.9%).

  1. Cme Group Inc Cl A+$517.7M+11%
  2. Merck And Co Inc+$477.6M+8%
  3. Tesla+$463.8M+26%
  4. Broadcom+$321.4M+3%
  5. Verizon Communications Inc+$196.1M+5%
  6. Lockheed Martin Corp−$1.39B−24%
  7. Dowdupont Inc−$1.43B−17%
  8. Home Depot Inc−$2.01B−17%
  9. Amazon−$2.17B−25%
  10. Microsoft−$2.37B−11%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$900.00B$450.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$846.43B+15%SEC ↗
Q1 2026$732.94B−0%SEC ↗
Q4 2025$735.30B+0%SEC ↗
Q3 2025$732.04B+6%SEC ↗
Q2 2025$687.95B+11%SEC ↗
Q1 2025$617.20B−6%SEC ↗
Q4 2024$658.71B+2%SEC ↗
Q3 2024$645.05B+5%SEC ↗
Q2 2024$613.27B+1%SEC ↗
Q1 2024$604.23B+7%SEC ↗
Q4 2023$562.26B+11%SEC ↗
Q3 2023$504.81B−3%SEC ↗
Q2 2023$519.91B+7%SEC ↗
Q1 2023$483.79B+3%SEC ↗
Q4 2022$469.11B+5%SEC ↗
Q3 2022$445.41B−5%SEC ↗
Q2 2022$470.72B−19%SEC ↗
Q1 2022$580.76B−8%SEC ↗
Q4 2021$632.21B+8%SEC ↗
Q3 2021$585.85B−0%SEC ↗
Q2 2021$588.43B+9%SEC ↗
Q1 2021$541.07B+4%SEC ↗
Q4 2020$518.94B+14%SEC ↗
Q3 2020$456.91B+11%SEC ↗
Q2 2020$413.27B+20%SEC ↗
Q1 2020$344.62B−23%SEC ↗
Q4 2019$447.39B+8%SEC ↗
Q3 2019$415.21B−3%SEC ↗
Q2 2019$426.29B+3%SEC ↗
Q1 2019$412.39B+12%SEC ↗
Q4 2018$369.11B−10%SEC ↗
Q3 2018$411.05B−12%SEC ↗
Q2 2018$467.29B+5%SEC ↗
Q1 2018$444.21B−4%SEC ↗
Q4 2017$461.25B+4%SEC ↗
Q3 2017$441.49B+4%SEC ↗
Q2 2017$425.76B+2%SEC ↗
Q1 2017$418.31B+5%SEC ↗
Q4 2016$397.60B+3%SEC ↗
Q3 2016$384.55B+4%SEC ↗
Q2 2016$370.85B+2%SEC ↗
Q1 2016$361.93BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.